Cargando…

Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma

An algorithm to describe patterns of intermittent oral corticosteroid use in the UK (n = 476,167) found that one-third of patients receiving intermittent oral corticosteroids for asthma only had short gaps (<90 days) between oral corticosteroid prescriptions sometime during follow-up. The increas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haughney, John, Tran, Trung N., Heatley, Heath, Bourdin, Arnaud, Menzies-Gow, Andrew, Jackson, David J., Maslova, Ekaterina, Chapaneri, Jatin, Skinner, Derek, Carter, Victoria, Chan, Jeffrey Shi Kai, Price, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985594/ https://www.ncbi.nlm.nih.gov/pubmed/36871120 http://dx.doi.org/10.1038/s41533-023-00331-0

Ejemplares similares

Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
por: Heatley, Heath, et al.
Publicado: (2023)

Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management
por: Bleecker, Eugene R., et al.
Publicado: (2020)

A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma
por: Haughney, John, et al.
Publicado: (2023)

Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety
por: Price, David, et al.
Publicado: (2020)

Long‐term corticosteroid use, adrenal insufficiency and the need for steroid‐sparing treatment in adult severe asthma
por: Gurnell, M., et al.
Publicado: (2021)

Global Quality Standard for Identification and Management of Severe Asthma
por: Haughney, John, et al.
Publicado: (2020)

Is There Any Point in a Corticosteroid Treatment of Intermittent Asthma?
por: Stanković, Ivana, et al.
Publicado: (2007)

Environmental Sustainability in Respiratory Care: An Overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) Programme
por: Wilkinson, Alex, et al.
Publicado: (2022)

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
por: Menzies-Gow, Andrew, et al.
Publicado: (2019)

Matching‐adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study
por: Soremekun, Seyi, et al.
Publicado: (2023)

Physicians’ attitudes towards combination therapy with inhaled corticosteroids and long-acting β(2)-agonists: an observational study in UK specialist care
por: Thomas, Mike, et al.
Publicado: (2011)

Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
por: Kemp, Linda, et al.
Publicado: (2010)

Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study
por: Price, David B, et al.
Publicado: (2018)

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
por: Voorham, Jaco, et al.
Publicado: (2018)

Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Current Control and Future Risk in Asthma Management
por: Sims, Erika J, et al.
Publicado: (2011)

Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies
por: Casale, Thomas B., et al.
Publicado: (2022)

The Biology of Eosinophils and Their Role in Asthma
por: McBrien, Claire N., et al.
Publicado: (2017)

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
por: Thomas, Mike, et al.
Publicado: (2009)

How can we minimise the use of regular oral corticosteroids in asthma?
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals’ perceptions of asthma control with validated ACT scores
por: Menzies-Gow, Andrew, et al.
Publicado: (2017)

Defining severe asthma – an approach to find new therapies
por: Nanzer, Alexandra M., et al.
Publicado: (2014)

A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD
por: Tse, Gary, et al.
Publicado: (2023)

Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme
por: Taillé, Camille, et al.
Publicado: (2020)

A Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

Holy Grail: the journey towards disease modification in asthma
por: Busse, William W., et al.
Publicado: (2022)

Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study
por: Tran, Trung N, et al.
Publicado: (2021)

Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma
por: Price, David, et al.
Publicado: (2021)

Targeting TSLP in Asthma
por: Parnes, Jane R, et al.
Publicado: (2022)

Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK
por: Tran, Trung N., et al.
Publicado: (2020)

Corticosteroids in the treatment of acute asthma
por: Alangari, Abdullah A.
Publicado: (2014)

Asthma: beyond corticosteroid treatment
por: Marandi, Yasser, et al.
Publicado: (2013)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

Benefits of specialist severe asthma management: demographic and geographic disparities
por: Redmond, Charlene, et al.
Publicado: (2022)

Short-acting β(2)-agonists and exacerbations in children with asthma in England: SABINA Junior
por: Morgan, Ann, et al.
Publicado: (2023)

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry
por: Sweeney, Joan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v5e719d7gdbhgaa3ig3qvfu4s4